Projects per year
Personal profile
Further information
Branches of science
- 211 Other Technical Sciences
- 301 Medical-Theoretical Sciences, Pharmacy
- 302 Clinical Medicine
Fingerprint
- 1 Similar Profiles
Most recent collaborations and top research areas
Projects
- 4 Finished
-
Opt-INFUSE: Optimising the timing of infusion set replacement in insulin pump therapy using tissue flow resistance monitoring
Pieber, T. (Principal investigator), Regittnig, W. (Co-investigator), Mattersdorfer, K. (Co-investigator), Senekowitsch, J. T. (Co-investigator) & Vera Ramos, J. A. (Co-investigator)
5/09/22 → 4/09/24
Project: Research funding
-
INNODIA_Horizon: Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
Pieber, T. (Principal investigator), Treiber, G. (Co-principal investigator), Fröhlich-Reiterer, E. (Co-principal investigator), Regittnig, W. (Co-investigator), Rohban, R. (Co-investigator), Kotzbeck, P. (Co-investigator), Kaineder, K. (Co-investigator), Ehall, B. (Co-investigator) & Harger, A. (Co-investigator)
1/11/15 → 31/10/23
Project: Research funding
-
PCDiab: A Portable bihormonal Closed Loop for Diabetes
Regittnig, W. (Principal investigator), Jungklaus, M. (Co-investigator), Tschaikner, M. (Co-investigator), Deutsch, F. G. (Co-investigator), Simic, A. (Co-investigator) & Tuca, A. (Co-investigator)
1/09/12 → 31/05/16
Project: Research funding
-
PORÖSER_GEWEBSKONTAKTIERER: Poröser Gewebskontaktierer
Regittnig, W. (Principal investigator)
1/06/06 → 31/03/07
Project: Research funding
-
Dapagliflozin reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
Svehlikova, E., Regittnig, W., Gatschelhofer, C., Höller, V., Fluhr, G., Lackner, B., Magnes, C., Eberl, A. & Pieber, T., Sept 2024, In: Diabetologia. 67, p. S128-S129 2 p.Research output: Contribution to journal › Conference abstract
-
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
Svehlikova, E., Regittnig, W., Gatschelhofer, C., Höller, V., Fluhr, G., Lackner, B., Magnes, C., Eberl, A. & Pieber, T., Sept 2024, In: Diabetologia. 67, p. S346-S347 2 p.Research output: Contribution to journal › Conference abstract
-
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
Svehlikova, E., Gatschelhofer, C., Regittnig, W., Fluhr, G., Höller, V., Lackner, B., Eberl, A., Magnes, C. & Pieber, T., 2024.Research output: Contribution to conference book › Conference abstract
-
SGLT2 inhibition reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
Svehlikova, E., Regittnig, W., Gatschelhofer, C., Höller, V., Fluhr, G., Lackner, B., Magnes, C., Eberl, A. & Pieber, T., 2024.Research output: Contribution to conference book › Conference abstract
-
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During Hypoglycemia.
Zenz, S. (First author), Regittnig, W., Boulgaropoulos, B., Augustin, T., Brunner, M., Korsatko, S., Münzker, J., Narath, S. H., Raml, R., Magnes, C. & Pieber, T. (Last author), 2022, In: Journal of Clinical Endocrinology and Metabolism.Research output: Contribution to journal › Research article
9 Citations (Web of Science)
-
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
Svehlikova, E. (Author), Regittnig, W. (Author), Gatschelhofer, C. (Author), Höller, V. (Author), Fluhr, G. (Author), Lackner, B. (Author), Magnes, C. (Author), Eberl, A. (Author) & Pieber, T. (Author)
2024Activity: Talk, presentation or poster › Poster
-
Dapagliflozin reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
Svehlikova, E. (Author), Regittnig, W. (Author), Gatschelhofer, C. (Author), Höller, V. (Author), Fluhr, G. (Author), Lackner, B. (Author), Magnes, C. (Author), Eberl, A. (Author) & Pieber, T. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
SGLT2 inhibition reduces endogenous glucose production during a period of acute insulin deprivation and development of ketoacidosis in people with type 1 diabetes
Svehlikova, E. (Speaker), Regittnig, W. (Author), Gatschelhofer, C. (Author), Höller, V. (Author), Fluhr, G. (Author), Lackner, B. (Author), Magnes, C. (Author), Eberl, A. (Author) & Pieber, T. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Glucagon as a potential promoter of sodium-glucose co-transporter 2 induced ketogenesis via effect on lipolysis
Svehlikova, E. (Speaker), Gatschelhofer, C. (Author), Regittnig, W. (Author), Fluhr, G. (Author), Höller, V. (Author), Lackner, B. (Author), Eberl, A. (Author), Magnes, C. (Author) & Pieber, T. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor.
Mursic, I. (Author), Svehlikova, E. (Author), Regittnig, W. (Author), Urschitz, M. (Author), Wolf, M. (Author), Brunner, M. (Author), Augustin, T. (Author), Magnes, C. (Author), Eberl, A. (Author), Heise, T. (Author), Klein, O. (Author), Sourij, H. (Author) & Pieber, T. (Author)
2020Activity: Talk, presentation or poster › Scientific talk or presentation › On site
Prizes
-
-
Innovation Award from the Austrian Society for Biomedical Engineering (ÖGBMT)
Regittnig, W. (Recipient), 2014
Prize
-
Scientific Session Travel Grant from the American Diabetes Association
Regittnig, W. (Recipient), 2002
Prize
-
Stefan-Schuy-Award from the Austrian Society for Biomedical Engineering
Regittnig, W. (Recipient), 1999
Prize
Thesis
-
Glucose dynamics in plasma and interstitial fluid after intravenous glucose injection.
Regittnig, W. (Author), 1998Student thesis: Doctoral thesis
-